Cardea SOLO™ Captures AFIB on Day 3

Background

A 74-year-old female presented to re-establish cardiology care after she was lost to follow-up for 4 years. Patient presented with complaints of right side of her mouth drooping and several episodes of having right side facial drooping that would resolve spontaneously. She denied confusion, difficulty with speech, lightheaded/dizziness or palpitations. The patient stated that she has not felt well for the last six months and her symptoms were also associated with fatigue.

Key Takeaways
‏‏‎ ‎

Patient presents with reported TIA symptoms
Cardea SOLO detects paroxysmal AFib on Day 3
Cardea SOLO findings also included runs of Tachycardia and SVT

Diagnostic Work Up

A resting 12-lead in-office EKG showed sinus bradycardia with old infarct, which was a new change for her. A Cardea SOLO™ ECG Sensor was ordered to assess for potential cardiac arrhythmias, given the sinus bradycardia findings on 12L ECG and suspected TIA based on reported symptoms.

A Cardea SOLO Sensor was applied on the same visit and worn for 6 full days. Significant findings included frequent runs of Tachycardias and Supraventricular Tachycardias (SVTs), a single 30-minute episode of paroxysmal atrial fibrillation (PAF) with rapid ventricular response (RVR) at a maximum rate of 184 BPM that terminated with a 4-second Pause. The PAF occurred on Day 3 of Sensor wear-time. Rare isolated PACs and PVCs were noted.

No Bradycardia runs or Ventricular Tachycardia occurred. Patient-Reported Events: 16 [SVT, PAC Isolated, PVC Isolated]. The patient’s diary entry with complaints of dizziness and fast heart rate corresponded to confirmed Atrial Fibrillation with RVR.

FIGURE 1. DAY 3 AF EPISODE WITH RVR

FIGURE 2. ONSET AF RHYTHM

FIGURE 3. OFFSET RHYTHM WITH 4-SECOND PAUSE

FIGURE 4. RHYTHM SIGNATURE™ SCATTERPLOT VISUALIZING DAY 3 AF EPISODE

Discussion

A standard 48-hour Holter monitor would have missed the single episode of symptomatic PAF findings, which occurred on Day 3 of ECG monitoring.

Cori Graham, Certified EKG Technician Amarillo Heart Group, Amarillo, Texas

Treatment

The patient’s treatment plan was established upon review and confirmation of Cardea SOLO report findings.

More Case Studies

New Onset AF Detected Early by Cardea SOLO®, Facilitating Anticoagulation and Reducing Stroke Risk

*Under Emergency Use Authorization during Covid-19 pandemic

Primary Care Practice detects AF with Cardea SOLO® Resulting in Seamless Treatment Plan

*Study was conducted in 2020.

Interventional Cardiologist uses Cardea SOLO® Wearable ECG Sensor to Diagnose New Onset Atrial Fibrillation in a Cardiology Clinic Setting

Cardea SOLO™ Captures AFIB on Day 3

Background

Key Takeaways
‏‏‎ ‎

Diagnostic Work Up

FIGURE 1. DAY 3 AF EPISODE WITH RVR

FIGURE 2. ONSET AF RHYTHM

FIGURE 3. OFFSET RHYTHM WITH 4-SECOND PAUSE

FIGURE 4. RHYTHM SIGNATURE™ SCATTERPLOT VISUALIZING DAY 3 AF EPISODE

Discussion

Treatment

More Case Studies

Innovation Meets Simplicity

Cardea SOLO

Cardea 20/20

Insights

Other Pages

Cardea SOLO™ Captures AFIB on Day 3

Background

Key Takeaways ‏‏‎ ‎

Diagnostic Work Up

FIGURE 1. DAY 3 AF EPISODE WITH RVR

FIGURE 2. ONSET AF RHYTHM

FIGURE 3. OFFSET RHYTHM WITH 4-SECOND PAUSE

FIGURE 4. RHYTHM SIGNATURE™ SCATTERPLOT VISUALIZING DAY 3 AF EPISODE

Discussion

Treatment

More Case Studies

Innovation Meets Simplicity

Cardea SOLO

Cardea 20/20

Insights

Other Pages

Key Takeaways
‏‏‎ ‎